Align Technology ALGN
NASDAQ ALGN
$162.55 +3.61 (+2.27%)
At close: Aug 21, 2026 · 4:00 PM EDT

Align Technology (ALGN) Liabilities and Shareholders Equity (2009 - 2026)

Align Technology (ALGN) posted quarterly Liabilities and Shareholders Equity of $6.3 billion for Q1 2026, up 3.46% year-over-year from $6.1 billion in Q1 2025, and up 1.29% quarter-over-quarter from $6.2 billion in Q4 2025.

Align Technology (ALGN) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Align Technology (ALGN) has reported Liabilities and Shareholders Equity for 18 consecutive years, with $6.3 billion the latest figure, recorded in Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity rose 3.46% year-over-year to $6.3 billion; the TTM figure through Mar 2026 stood at $25.0 billion (up 0.64% YoY), while the FY2025 annual figure was $6.2 billion, changed 0.31% from the prior year.
  • Liabilities and Shareholders Equity climbed to $6.3 billion in Q1 2026 per ALGN's latest filing, from $6.2 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $6.4 billion in Q3 2024 and bottomed at $5.8 billion in Q2 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $6.1 billion across 5 years, with a median of $6.2 billion in 2024.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity rose 17.23% — and 2025, when it declined 2.08%.
  • Align Technology's Liabilities and Shareholders Equity stood at $5.9 billion in 2022, then rose by 2.29% to $6.1 billion in 2023, then advanced by 2.15% to $6.2 billion in 2024, then climbed by 0.31% to $6.2 billion in 2025, then gained by 1.29% to $6.3 billion in 2026.
  • Business Quant data shows ALGN's Liabilities and Shareholders Equity at $6.3 billion in Q1 2026, $6.2 billion in Q4 2025, and $6.2 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 20.88 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 50.73 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn 31.10 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 8.97 Bn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 39.35 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 4.08 Bn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 14.24 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn 12.48 Bn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 19.79 Bn
10 Align Technology 11.61 Bn 10.51 Bn 757.43 Mn 6.42 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 6.42 Bn
Mar 31, 2026 6.31 Bn
Dec 31, 2025 6.23 Bn
Sep 30, 2025 6.23 Bn
Jun 30, 2025 6.22 Bn
Mar 31, 2025 6.10 Bn
Dec 31, 2024 6.21 Bn
Sep 30, 2024 6.37 Bn
Jun 30, 2024 6.16 Bn
Mar 31, 2024 6.16 Bn
Dec 31, 2023 6.08 Bn
Sep 30, 2023 6.32 Bn
Jun 30, 2023 6.14 Bn
Mar 31, 2023 5.90 Bn
Dec 31, 2022 5.95 Bn
Sep 30, 2022 5.91 Bn
Jun 30, 2022 5.81 Bn
Mar 31, 2022 5.94 Bn
Dec 31, 2021 5.94 Bn
Sep 30, 2021 5.65 Bn